This website uses cookies so that we can offer you the best possible user experience. The cookie information is stored in your browser and performs functions such as recognizing you when you return to our website or helping our team to understand which sections of the website you find most interesting and useful.
The KÆRTOR Foundation
The Kærtor Foundation is an initiative of global reach, a pioneer in open innovation and public-private co-development in drug discovery. It provides continuity to the results of the University of Santiago de Compostela (USC) Innopharma project and is led by Professors Mabel Loza, a specialist in Pharmacology, and Ángel Carracedo, a specialist in Genomic Medicine.
A PIONEER RESEARCH INITIATIVE FOR EARLY DRUG DISCOVERY IN COLLABORATION WITH INDUSTRY
Our mission is to promote the reciprocal transfer of knowledge in a circular, translational drug discovery process, generating synergies that increase the value and accelerate the procedure.
Call for Expressions of Interest open
million euros for early drug discovery
EoIs received in total
strategic agreements in reverse transfer
THE MAIN AIMS OF THE
KÆRTOR FOUNDATION
WHAT IS REVERSE TRANSFER?
- The application of transformational science in disease mechanisms to medical and industrial demands
- Finding the best ideas anywhere in the world and applying them in Galicia with the pharmaceutical companies